The Enterprise Value as of December 2025 (TTM) for YD Bio Limited Ordinary Shares (YDES) is 900.55M

According to YD Bio Limited Ordinary Shares’s latest financial reports and current stock price. The company's current Enterprise Value is 900.55M. This represents a change of 1.91% compared to the average of 44.81M of the last 4 quarters.

YD Bio Limited Ordinary Shares (YDES) Historical Enterprise Value (quarterly & annually)

How has YDES Enterprise Value performed in the past?

The mean historical Enterprise Value of YD Bio Limited Ordinary Shares over the last ten years is 270.83M. The current 900.55M Enterprise Value has changed 33.15% with respect to the historical average. Over the past ten years (40 quarters), YDES's Enterprise Value was at its highest in in the December 2023 quarter at 51.76M. The Enterprise Value was at its lowest in in the June 2025 quarter at 41.04M.

YD Bio Limited Ordinary Shares (YDES) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of YD Bio Limited Ordinary Shares Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

YD Bio Limited Ordinary Shares (YDES) Average Enterprise Value

How has YDES Enterprise Value performed in the past?

The current Enterprise Value of YD Bio Limited Ordinary Shares (YDES) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

YD Bio Limited Ordinary Shares (YDES) Enterprise Value vs. Peers

How is YDES’s Enterprise Value compared to its peers?

YD Bio Limited Ordinary Shares’s Enterprise Value is greater than Vir Biotechnology, Inc. (737.27M), less than Maravai LifeSciences Holdings, Inc. (1.74B), greater than Theravance Biopharma, Inc. (817.41M), greater than Geron Corporation (854.51M), greater than LENZ Therapeutics, Inc. (742.15M), greater than Day One Biopharmaceuticals, Inc. (815.93M), less than Monte Rosa Therapeutics, Inc. (1.10B), greater than Prime Medicine, Inc. (728.20M), greater than BlackRock Technology and Private Equity Term Trust (786.63M), less than Tyra Biosciences, Inc. (1.09B),

Build a custom stock screener for YD Bio Limited Ordinary Shares (YDES) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like YD Bio Limited Ordinary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

YD Bio Limited Ordinary Shares (YDES) and other stocks custom spreadsheet templates

The easiest way to analyze a company like YD Bio Limited Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.